Prognostic markers of COPD patients followed by 10 years in a specialized center in Brazil.

J. Fortes Cré (São Paulo, Brazil), A. Borges Amaral (São Paulo, Brazil), L. Buassali Fredini (São Paulo, Brazil), L. Polito Bianchini (São Paulo, Brazil), S. Quaranta Damião (São Paulo, Brazil), A. Consuli Alvarez (São Paulo, Brazil), G. Meira Sacardo (São Paulo, Brazil), E. Fiss (São Paulo (SP), Brazil), M. Silveira Lapa (São Paulo (SP), Brazil)

Source: Virtual Congress 2020 – Investigations of COPD
Session: Investigations of COPD
Session type: E-poster session
Number: 3283
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Fortes Cré (São Paulo, Brazil), A. Borges Amaral (São Paulo, Brazil), L. Buassali Fredini (São Paulo, Brazil), L. Polito Bianchini (São Paulo, Brazil), S. Quaranta Damião (São Paulo, Brazil), A. Consuli Alvarez (São Paulo, Brazil), G. Meira Sacardo (São Paulo, Brazil), E. Fiss (São Paulo (SP), Brazil), M. Silveira Lapa (São Paulo (SP), Brazil). Prognostic markers of COPD patients followed by 10 years in a specialized center in Brazil.. 3283

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of cases from an interstitial lung disease (ILD) MDT in a teaching hospital in the West Midlands: Patients with smoking-related disease comprise 11% of cases and have a median age of 50 years
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012


Survival analysis of PAH patients based on a multidimensional risk approach at baseline in Uruguay: 10 years of experience of a PH referral centre.
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Malignant patients under 40 years of age hospitalised and treated in clinic for lung diseases of clinical center of Sarajevo university
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


Lung cancer: 20 years of watching the patients at the clinical department for the lung diseases in the area of South Croatia
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Clinical characteristics and outcomes of community acquired pneumonia (CAP) in adults ≥18 years of age in a well defined area of Badalona, Spain
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


The obstructive lung disease in northern Sweden (OLIN) longitudinal paediatric study I – the first 10 years
Source: Annual Congress 2008 - Asthma epidemiology
Year: 2008

Causes of death in COPD patients in primary care setting - 6 years follow-up
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Prognostic factors in COPD patients controlled in two outpatient clinics
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012


Exacerbation rates of COPD in hospital patients, population based cases and controls
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009


Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Cost-effectiveness of an early supported discharge service (ESDS) for chronic obstructive pulmonary disease (COPD) in a university hospital serving a large rural population
Source: Annual Congress 2007 - Ethical and economic choices in respiratory care
Year: 2007



Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eEPOC) in Spain. Mortality and readmission at 90 days of patients admitted for eEPOC. Influence of hospitalization department
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009

Clinical and epidemiological patterns of pediatric patients with mycobacterial disease at the TB reference centre in Milan
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011


Patterns of initial treatment for COPD according to clinical phenotypes in Catalonia
Source: International Congress 2015 – COPD: notable points
Year: 2015

Course and prognosis of sarcoidosis in a referral setting in Turkey; analysis of 166 patients
Source: Eur Respir J 2005; 26: Suppl. 49, 596s
Year: 2005